Biliary Tract: Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis (PSC)

Basics

  • Chronic Autoimmune Fibrosis of the Biliary Tract
  • Affects Intrahepatic Bile Ducts (15%), Extrahepatic Bile Ducts (10%) or Both (75%)
  • May See Multiple Strictures Throughout the Entire Biliary Tree
  • Most Common in Men
  • Strongly Associated with IBD (Especially Ulcerative Colitis)
    • Prevalence: 60-90%
    • No Improvement After Colon Resection
  • High Risk of Cholangiocarcinoma (10-20%)

Presentation

  • Causes Biliary Stricture with Chronic Cholestasis & Eventual Cirrhosis
  • Commonly ASx at Diagnosis
  • Sx: Fatigue, Pruritis, Abdominal Pain & Jaundice
  • May Show Signs of Decompensated Liver Failure if Presenting Late

Diagnosis

  • Dx: MRCP/ERCP (“Beaded” Bile Ducts)
  • Labs:
    • Elevated LFT’s; Particularly Alkaline Phosphatase
    • Atypical P-ANCA (Perinuclear Antineutrophil Cytoplasmic Antibody)
    • Always Check CA 19-9 for CA
    • Always Check IgG4
  • Immediate Colonoscopy on Dx to Evaluate for IBD

Treatment

  • Temporary/Sx Relief:
    • Ursodeoxycholic Acid (UDCA)
    • If Dominant Extrahepatic Strictures: Consider ERCP & Stent
    • Other Potential Medical Options: Cyclosporine, Methotrexate, Azathioprine or ABX
    • Avoid:
      • Generally Avoid Choledochojejunostomy as TXP is Preferred
      • No Benefit: Cholestyramine or Colchicine
  • Definitive Tx: Liver TXP

Cancer Screening After Diagnosis

  • Abdominal US or MRI/MRCP Every 6-12 Months
  • CA 19-9 Every 1 Year
  • Colonoscopy at Diagnosis & Every 1-2 Years

PSC with “Beaded” Bile Ducts on MRCP 1

IgG4-Associated Cholangitis

Basics

  • Most Frequent Extra-Pancreatic Manifestation of Autoimmune Pancreatitis
    • Rarely Occurs in Absence of Pancreatitis
  • Possibly Manifestation of Same Disease as PSC

Treatment

  • Tx: Steroids

References

  1. Worthington J, Chapman R. Primary sclerosing cholangitis. Orphanet J Rare Dis. 2006 Oct 24;1:41. (License: CC BY-2.0)